// App-Quantinova.ai

3128 : Detection of genetic and epigenetic DNA markers in urine for the early detection of primary and recurrent HCC

Researchers

Presenter

  • Surbhi Jain

Principal Investigators

  • Hie-Won Hann

  • Sitong Chen

  • Selena Y. Lin

  • Ting-Tsung Chang

  • Chi-Tan Hu

  • Wei Song

  • Ying-Hsiu Su

Medical Centers

  • JBS Science, Inc, Doylestown, PA

  • Liver Disease Prevention Center, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA

  • Drexel Univ Coll of Medcn, Philadelphia, PA

  • National Cheng Kung University Medical College, Tainan, Taiwan.

  • Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan.

  • Baruch S. Blumberg Institute, Doylestown, PA

Locations

  • United States

  • Taiwan

Companies

  • JBS Science, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • beta-catenin

  • Ras Association Domain Family Member 1

  • Glutathione S-transferase P1

  • Telomerase reverse transcriptase

  • Tumor protein p53

  • DNA methylation

Drug/Treatment

  • Alfa-fetoprotein

  • TP53

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved